South Korea · Delayed Price · Currency is KRW NEUROPHET Statistics
Total Valuation
NEUROPHET has a market cap or net worth of KRW 83.81 billion. The enterprise value is 45.53 billion.
| Market Cap | 83.81B |
| Enterprise Value | 45.53B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NEUROPHET has 12.20 million shares outstanding.
| Current Share Class | 12.20M |
| Shares Outstanding | 12.20M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.63% |
| Owned by Insiders (%) | 39.56% |
| Owned by Institutions (%) | 10.83% |
| Float | 6.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.36 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.20, with a Debt / Equity ratio of 0.19.
| Current Ratio | 21.20 |
| Quick Ratio | 20.74 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | -35.53 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -41.02% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -596.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -57.33% |
| 50-Day Moving Average | 7,756.40 |
| 200-Day Moving Average | 17,783.25 |
| Relative Strength Index (RSI) | 36.78 |
| Average Volume (20 Days) | 35,228 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NEUROPHET had revenue of KRW 2.59 billion and -23.10 billion in losses. Loss per share was -1,969.42.
| Revenue | 2.59B |
| Gross Profit | 2.58B |
| Operating Income | -19.63B |
| Pretax Income | -23.62B |
| Net Income | -23.10B |
| EBITDA | -18.49B |
| EBIT | -19.63B |
| Loss Per Share | -1,969.42 |
Balance Sheet
The company has 45.52 billion in cash and 6.55 billion in debt, with a net cash position of 38.97 billion or 3,194.55 per share.
| Cash & Cash Equivalents | 45.52B |
| Total Debt | 6.55B |
| Net Cash | 38.97B |
| Net Cash Per Share | 3,194.55 |
| Equity (Book Value) | 35.30B |
| Book Value Per Share | 2,836.36 |
| Working Capital | 45.08B |
Cash Flow
In the last 12 months, operating cash flow was -17.71 billion and capital expenditures -534.00 million, giving a free cash flow of -18.24 billion.
| Operating Cash Flow | -17.71B |
| Capital Expenditures | -534.00M |
| Depreciation & Amortization | 1.15B |
| Net Borrowing | 15.34B |
| Free Cash Flow | -18.24B |
| FCF Per Share | -1,495.58 |
Margins
| Gross Margin | 99.77% |
| Operating Margin | -758.18% |
| Pretax Margin | -912.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NEUROPHET does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -27.57% |
| FCF Yield | -21.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NEUROPHET has an Altman Z-Score of 7.05 and a Piotroski F-Score of 1.
| Altman Z-Score | 7.05 |
| Piotroski F-Score | 1 |